Hu X, De Silva TM, Chen J, Faraci FM. Cerebral vascular Disease and Neurovascular Injury in ischemic Stroke. Circ Res. 2017;120(3):449–71.
Article CAS PubMed PubMed Central Google Scholar
Levine DA, Chen B, Galecki AT, Gross AL, Briceño EM, Whitney RT, Ploutz-Snyder RJ, Giordani BJ, Sussman JB, Burke JF, et al. Associations between vascular risk factor levels and cognitive decline among Stroke survivors. JAMA Netw Open. 2023;6(5):e2313879.
Article PubMed PubMed Central Google Scholar
Levine DA, Galecki AT, Langa KM, Unverzagt FW, Kabeto MU, Giordani B, Wadley VG. Trajectory of cognitive decline after Incident Stroke. JAMA. 2015;314(1):41–51.
Article CAS PubMed PubMed Central Google Scholar
Chang CWJ, Provencio JJ, Shah S. Neurological critical care: the evolution of cerebrovascular critical care. Crit Care Med. 2021;49(6):881–900.
Harshfield EL, Markus HS. Association of Baseline Metabolomic profiles with Incident Stroke and Dementia and with imaging markers of Cerebral Small Vessel Disease. Neurology. 2023;101(5):e489–e501.
Article CAS PubMed PubMed Central Google Scholar
Yamada T, Shojima N, Hara K, Noma H, Yamauchi T, Kadowaki T. Glycemic control, mortality, secondary Infection, and hypoglycemia in critically ill pediatric patients: a systematic review and network meta-analysis of randomized controlled trials. Intensive Care Med. 2017;43(9):1427–9.
Bohé J, Abidi H, Brunot V, Klich A, Klouche K, Sedillot N, Tchenio X, Quenot JP, Roudaut JB, Mottard N, et al. Individualised versus conventional glucose control in critically-ill patients: the CONTROLING study-a randomized clinical trial. Intensive Care Med. 2021;47(11):1271–83.
PubMed PubMed Central Google Scholar
Takahashi H, Iwahashi N, Kirigaya J, Kataoka S, Minamimoto Y, Gohbara M, Abe T, Okada K, Matsuzawa Y, Konishi M, et al. Glycemic variability determined with a continuous glucose monitoring system can predict prognosis after acute coronary syndrome. Cardiovasc Diabetol. 2018;17(1):116.
Article CAS PubMed PubMed Central Google Scholar
Hanajima Y, Iwahashi N, Kirigaya J, Horii M, Minamimoto Y, Gohbara M, Abe T, Okada K, Matsuzawa Y, Kosuge M, et al. Prognostic importance of glycemic variability on left ventricular reverse remodeling after the first episode of ST-segment elevation Myocardial Infarction. Cardiovasc Diabetol. 2023;22(1):202.
Article CAS PubMed PubMed Central Google Scholar
Ceriello A, Monnier L, Owens D. Glycaemic variability in Diabetes: clinical and therapeutic implications. Lancet Diabetes Endocrinol. 2019;7(3):221–30.
Krinsley JS, Grover A. Severe hypoglycemia in critically ill patients: risk factors and outcomes. Crit Care Med. 2007;35(10):2262–7.
Bagshaw SM, Bellomo R, Jacka MJ, Egi M, Hart GK, George C. The impact of early hypoglycemia and blood glucose variability on outcome in critical Illness. Crit Care. 2009;13(3):R91.
Article PubMed PubMed Central Google Scholar
Echouffo-Tcheugui JB, Zhao S, Brock G, Matsouaka RA, Kline D, Joseph JJ. Visit-to-visit Glycemic Variability and risks of Cardiovascular events and all-cause mortality: the ALLHAT Study. Diabetes Care. 2019;42(3):486–93.
Article PubMed PubMed Central Google Scholar
Mitsios JP, Ekinci EI, Mitsios GP, Churilov L, Thijs V. Relationship between glycated hemoglobin and Stroke risk: a systematic review and Meta-analysis. J Am Heart Assoc 2018, 7(11).
Xu Y, Dong S, Fu EL, Sjölander A, Grams ME, Selvin E, Carrero JJ. Long-term visit-to-visit variability in Hemoglobin A(1c) and kidney-related outcomes in persons with Diabetes. Am J Kidney Dis 2023.
Pouryousefi E, Javadi M, Hashemipour S, Nooshabadi MR, Haghighian HK. Improved glycemic status, insulin resistance and inflammation after receiving oral oleoylethanolamide supplement in people with prediabetes: a randomized controlled trial. Diabetol Metab Syndr. 2022;14(1):77.
Article CAS PubMed PubMed Central Google Scholar
Mohandes S, Doke T, Hu H, Mukhi D, Dhillon P, Susztak K. Molecular pathways that drive diabetic Kidney Disease. J Clin Invest 2023, 133(4).
Nuthikattu S, Milenkovic D, Norman JE, Rutledge J, Villablanca A. Inhibition of Soluble Epoxide hydrolase is protective against the Multiomic effects of a high Glycemic Diet on Brain Microvascular inflammation and cognitive dysfunction. Nutrients 2021, 13(11).
Taylor MK, Sullivan DK, Swerdlow RH, Vidoni ED, Morris JK, Mahnken JD, Burns JM. A high-glycemic diet is associated with cerebral amyloid burden in cognitively normal older adults. Am J Clin Nutr. 2017;106(6):1463–70.
Article CAS PubMed PubMed Central Google Scholar
Gentreau M, Raymond M, Chuy V, Samieri C, Féart C, Berticat C, Artero S. High glycemic load is Associated with Cognitive decline in apolipoprotein E ε4 allele carriers. Nutrients 2020, 12(12).
Ceriello A, Esposito K, Piconi L, Ihnat MA, Thorpe JE, Testa R, Boemi M, Giugliano D. Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients. Diabetes. 2008;57(5):1349–54.
Article CAS PubMed Google Scholar
McCrimmon RJ, Ryan CM, Frier BM. Diabetes and cognitive dysfunction. Lancet. 2012;379(9833):2291–9.
Bergenstal RM. Glycemic variability and Diabetes Complications: does it Matter? Simply put, there are better glycemic markers! Diabetes Care. 2015;38(8):1615–21.
Hirsch IB. Glycemic variability and Diabetes Complications: does it Matter? Of Course it does! Diabetes Care. 2015;38(8):1610–4.
Article CAS PubMed Google Scholar
Johnson AEW, Bulgarelli L, Shen L, Gayles A, Shammout A, Horng S, Pollard TJ, Hao S, Moody B, Gow B, et al. MIMIC-IV, a freely accessible electronic health record dataset. Sci Data. 2023;10(1):1.
Article CAS PubMed PubMed Central Google Scholar
Caprio FZ, Sorond FA. Cerebrovascular Disease: primary and secondary Stroke Prevention. Med Clin North Am. 2019;103(2):295–308.
Grant PJ, Cosentino F. The 2019 ESC guidelines on diabetes, pre-diabetes, and Cardiovascular Diseases developed in collaboration with the EASD: new features and the ‘Ten commandments’ of the 2019 guidelines are discussed by Professor Peter J. Grant and Professor Francesco Cosentino, the Task Force chairmen. Eur Heart J. 2019;40(39):3215–7.
Meschia JF, Bushnell C, Boden-Albala B, Braun LT, Bravata DM, Chaturvedi S, Creager MA, Eckel RH, Elkind MS, Fornage M et al. Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2014, 45(12):3754–3832.
Sarwar N, Gao P, Seshasai SR, Gobin R, Kaptoge S, Di Angelantonio E, Ingelsson E, Lawlor DA, Selvin E, Stampfer M, et al. Diabetes Mellitus, fasting blood glucose concentration, and risk of vascular Disease: a collaborative meta-analysis of 102 prospective studies. Lancet. 2010;375(9733):2215–22.
Article CAS PubMed Google Scholar
Chang JY, Kim WJ, Kwon JH, Lee JS, Kim BJ, Kim JT, Lee J, Cha JK, Kim DH, Cho YJ, et al. Association of Prestroke Glycemic Control with vascular events during 1-Year follow-up. Neurology. 2021;97(17):e1717–26.
Article CAS PubMed Google Scholar
Rawlings AM, Sharrett AR, Mosley TH, Ballew SH, Deal JA, Selvin E. Glucose peaks and the risk of Dementia and 20-Year cognitive decline. Diabetes Care. 2017;40(7):879–86.
Article CAS PubMed PubMed Central Google Scholar
He J, Li S, Liu F, Zheng H, Yan X, Xie Y, Li X, Zhou Z, Zhu X. Glycemic control is related to cognitive dysfunction in Chinese children with type 1 Diabetes Mellitus. J Diabetes. 2018;10(12):948–57.
Lheureux O, Prevedello D, Preiser JC. Update on glucose in critical care. Nutrition. 2019;59:14–20.
Article CAS PubMed Google Scholar
Doola R, Greer RM, Hurford R, Flatley C, Forbes JM, Todd AS, Joyce CJ, Sturgess DJ. Glycaemic variability and its association with enteral and parenteral nutrition in critically ill ventilated patients. Clin Nutr. 2019;38(4):1707–12.
Russo VC, Higgins S, Werther GA, Cameron FJ. Effects of fluctuating glucose levels on neuronal cells in vitro. Neurochem Res. 2012;37(8):1768–82.
Article CAS PubMed Google Scholar
Rizzo MR, Marfella R, Barbieri M, Boccardi V, Vestini F, Lettieri B, Canonico S, Paolisso G. Relationships between daily acute glucose fluctuations and cognitive performance among aged type 2 diabetic patients. Diabetes Care. 2010;33(10):2169–74.
Article PubMed PubMed Central Google Scholar
Mo Y, Wang C, Lu J, Shen Y, Chen L, Zhang L, Lu W, Zhu W, Xia T, Zhou J. Impact of short-term glycemic variability on risk of all-cause mortality in type 2 Diabetes patients with well-controlled glucose profile by continuous glucose monitoring: a prospective cohort study. Diabetes Res Clin Pract. 2022;189:109940.
Article CAS PubMed Google Scholar
Cai J, Yang Q, Lu J, Shen Y, Wang C, Chen L, Zhang L, Lu W, Zhu W, Xia T, et al. Impact of the complexity of glucose Time Series on all-cause mortality in patients with type 2 Diabetes. J Clin Endocrinol Metab. 2023;108(5):1093–100.
Ma H, Yu G, Wang Z, Zhou P, Lv W. Association between dysglycemia and mortality by Diabetes status and risk factors of dysglycemia in critically ill patients: a retrospective study. Acta Diabetol. 2022;59(4):461–70.
Article CAS PubMed Google Scholar
Gerbaud E, Bouchard de La Poterie A, Baudinet T, Montaudon M, Beauvieux MC, Lemaître AI, Cetran L, Seguy B, Picard F, Vélayoudom FL et al. Glycaemic variability and hyperglycaemia as prognostic markers of Major Cardiovascular events in Diabetic patients Hospitalised in Cardiology Intensive Care Unit for Acute Heart Failure. J Clin Med 2022, 11(6).
Chun KH,
Comments (0)